亿帆医药股份有限公司关于调剂担保额度及为全资子公司提供担保的进展公告

Group 1 - The company has approved a total credit limit of up to RMB 650 million (or equivalent foreign currency) for itself and its subsidiaries, with a guarantee limit of up to RMB 600 million (or equivalent foreign currency) [1][4] - The company has adjusted the unused guarantee limit of RMB 24 million to its wholly-owned subsidiary Fisiopharma S.r.l., increasing the guarantee from RMB 0 to RMB 24 million [2][3] - The company will provide a joint liability guarantee of up to EUR 2.7 million for Fisiopharma's financing needs from Intesa Sanpaolo S.p.A and Banco BPM S.p.A [3][8] Group 2 - Fisiopharma S.r.l. is a wholly-owned subsidiary of the company, established in 1989, with a registered capital of EUR 2.645 million, focusing on the research, production, and sales of sterile preparations and other pharmaceuticals [5][6] - The company has confirmed that the financial risks associated with the guarantee are within its control, and the guarantee complies with relevant regulations [11] - As of the report date, the total external guarantee balance of the company and its subsidiaries is RMB 5.252 billion, accounting for 61.63% of the company's audited net assets for 2024 [13]